IGC Pharma, Inc.IGCNYSE

Revenue (LTM)

$1M

-5.5% YoY

Net Income (LTM)

$-7M

+45.2% YoY

Free Cash Flow

$-5M

Revenue CAGR (5Y)

-20.8%

Marginsimproving

FCF($0.0B)

Unprofitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	1	0↓55.8%	1↑129.5%	1↑47.6%	1↓5.5%
Gross Profit	-0	0↑155.6%	-0↓181.4%	1↑563.9%	1↓15.6%
Operating Income	-9	-15↓76.8%	-12↑25.0%	-10↑15.3%	-7↑24.0%
Net Income	-9	-15↓70.4%	-12↑23.4%	-13↓13.0%	-7↑45.2%
EBITDA	-8	-14↓72.4%	-11↑24.5%	-9↑15.6%	-7↑25.5%
EPS Diluted	-0.21	-0.30↓42.9%	-0.22↑26.7%	-0.22↓0.0%	-0.09↑57.7%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	15	10↓28.1%	3↓69.4%	1↓62.5%	0↓66.2%
Total Current Assets	24	15↓35.7%	6↓57.2%	4↓42.7%	3↓21.8%
Total Assets	36	27↓25.2%	17↓36.0%	10↓42.4%	9↓11.7%
Total Current Liabilities	2	2↑3.1%	2↓22.2%	2↑23.3%	2↓3.5%
Total Liabilities	3	3↓4.0%	2↓22.9%	3↑13.9%	2↓6.4%
Total Equity	33	24↓27.2%	15↓37.6%	7↓50.9%	6↓13.5%
Total Debt	1	1↓43.2%	0↓21.3%	0↓27.7%	0↓31.6%
Net Debt	-13	-10↑26.9%	-3↑72.4%	-1↑68.7%	-0↑80.4%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	-11	-7↑30.9%	-7↑5.6%	-5↑26.2%	-5↑7.8%
Capital Expenditure	-2	-1↑51.6%	-1↑19.7%	-1↑16.8%	-0↑6.4%
Free Cash Flow	-12	-8↑33.6%	-8↑6.9%	-6↑25.5%	-5↑7.6%
Stock-Based Comp	1	2↑233.9%	3↑29.4%	2↓37.6%	2↓7.5%
Net Change in Cash	7	-4↓156.1%	-7↓77.7%	-2↑72.5%	-1↑60.3%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance